Muscular Dystrophy Association Awards $1 Million to Tivorsan Pharmaceuticals, Inc. for Accelerating Pivotal Pre-Clinical Work on TVN-102 as a Potential Muscular Dystrophy Treatment
1/5/2012 11:06:24 AM
More...
|
Tivorsan Pharmaceuticals, Inc.' Biglycan for Duchenne Muscular Dystrophy Named One of Windhover Information Inc.'s Top 10 “Hot Space” Projects to Watch
10/19/2011 10:34:38 AM
More...
|
Tivorsan Pharmaceuticals, Inc.' Biglycan Protein Opens Unique Path for Preserving Muscle Function in Duchenne Muscular Dystrophy
12/28/2010 8:52:28 AM
More...
|
Brown University Licenses Potential Muscular Dystrophy Treatment To Tivorsan Pharmaceuticals, Inc.
9/21/2010 9:28:59 AM
More...
|